Abstract
Steroid-resistant nephrotic syndrome (SRNS) is a relatively difficult clinical type of treatment.The major therapy measures in present include steroid and immunosuppressant.Commonly used immunosuppressant include tacrolimus, cyclosporin, cyclophosphamide, mycophenolate mofetil, ect.Tacrolimus-induced clinical remission rate is superior to other immunosuppressive agents, has been the first-line agent of SRNS.Because of the individual difference in metabolism, the drug concentration of tacrolimus should be determined periodically.In order to obtain optimal efficacy of tacrolimus and reduce renal toxicity, the treatment protocols of small doses with long courses for children with SRNS were recommended. Key words: Tacrolimus; Child; Steroid-resistant; Idiopathic nephrotic syndrome
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
